Format

Send to

Choose Destination
See comment in PubMed Commons below
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008403. doi: 10.1002/14651858.CD008403.pub2.

Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children.

Author information

  • 1Pediatric Surgical Center of Amsterdam, EmmaChildren’sHospital / AcademicMedical Center, Amsterdam,Netherlands.

Update in

  • Cochrane Database Syst Rev. 2015;1:CD008403.

Abstract

BACKGROUND:

Minimally invasive surgery (MIS) is an accepted surgical technique for the treatment of a variety of benign diseases. Presently, the use of MIS in patients with cancer is progressing. However, the role of MIS in children with solid neoplasms is less clear than it is in adults. Diagnostic MIS to obtain biopsy specimens for pathology has been accepted as a technique in paediatric surgical oncology, but there is limited experience with the use of MIS for the resection of malignancies.

OBJECTIVES:

To ascertain the differences in outcome between the minimally invasive and open approach in the treatment of solid intra-thoracic and intra-abdominal neoplasms in children, regarding overall survival, event-free survival, port-site metastases, recurrence rate and surgical morbidity.

SEARCH METHODS:

We searched the electronic databases of MEDLINE/PubMed (from 1966 to February 2011), EMBASE/Ovid (from 1980 to February 2011) and CENTRAL (The Cochrane Library 2011, Issue 1) with pre-specified terms. In addition, we searched reference lists of relevant articles and reviews, conference proceedings and ongoing trial databases.

SELECTION CRITERIA:

Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) comparing MIS and open surgery for the treatment of solid intra-thoracic or intra-abdominal neoplasms in children (aged 0 to 18 years).

DATA COLLECTION AND ANALYSIS:

Two authors performed the study selection independently.

MAIN RESULTS:

No studies that met the inclusion criteria of this review were identified.

AUTHORS' CONCLUSIONS:

No RCTs or CCTs evaluating MIS in the treatment of solid intra-thoracic or intra-abdominal neoplasms in children could be identified, therefore no definitive conclusions could be made about the effects of MIS in these patients. Based on the currently available evidence we are not able to give recommendations for the use of MIS in the treatment of solid intra-thoracic or intra-abdominal neoplasms in children. More high quality studies (RCTs and/or CCTs) are needed. To accomplish this, centres specialising in MIS in children should collaborate.

PMID:
22258984
DOI:
10.1002/14651858.CD008403.pub2
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center